Hypertension-attributable mortality among older adult cancer survivors.
TL;DR
Hypertension diagnosed after cancer diagnosis was associated with a notable proportion of all-cause mortality among older adult cancer survivors, with variation by cancer site and race and ethnicity.
Abstract
659 Background: Hypertension is a common and modifiable cardiovascular risk factor among cancer survivors. However, the burden of mortality attributable to hypertension developing after cancer diagnosis remains poorly understood. We therefore estimated the proportion of deaths attributable to incident hypertension among cancer survivors over 65 years of age and explored differences by race/ethnicity. Methods: Using SEER-Medicare data (2003-2020), we identified Medicare beneficiaries aged 66-85 diagnosed with invasive cancer between 2004 and 2019 and were free of hypertension before cancer diagnosis. Population attributable fractions (PAFs) for all-cause mortality associated with incident hypertension were estimated overall and by cancer site using Cox proportional hazards regression models adjusted for cancer stage, sex, race and ethnicity, comorbidities, diagnosis year, treatment types, and number of primary care visits (time-varying). Secondary analysis examined PAFs by race and ethnicity. Results: The cohort consisted of 393,474 cancer survivors who were free of hypertension at diagnosis. Overall, hypertension diagnosed after cancer diagnosis accounted for 4.5% (95% confidence interval [CI]: 4.1, 5.1) of all-cause mortality among cancer survivors. The highest adjusted PAFs were observed among survivors of prostate cancer (11.4%, 95% CI: 9.3, 13.7), female breast cancer (10.7%, 95% CI: 8.5, 13.4), multiple myeloma (9.2%, 95% CI: 5.2, 13.2), and kidney/renal pelvis cancer (7.4%, 95% CI: 2.0, 12.2). In contrast, PAFs were low for colorectal (0.8%, 95% CI: -0.9, 2.7) and ovarian (1.3%, 95% CI: -1.9, 4.3) cancers. The highest race-specific PAF was observed among non-Hispanic Black survivors (7%) followed by Non-Hispanic White survivors (5%), whereas Hispanic and non-Hispanic Asian/Pacific Islander survivors each had PAFs of 2%. Conclusions: Hypertension diagnosed after cancer diagnosis was associated with a notable proportion of all-cause mortality among older adult cancer survivors, with variation by cancer site and race and ethnicity. Efforts to improve hypertension detection, monitoring, and management in cancer survivors may reduce mortality and help address disparities in survivorship outcomes.